Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of Gut Microbiome Biomarkers Associated to Acquisition of Enterobacteriae Highly Resistant to Third Generation Cephalosporines Following Ceftriaxone Treatment.

NCT03569917 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT03569917
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03569917 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of Gut Microbiome Biomarkers Associated to Acquisition of Enterobacteriae Highly Resistant to Third Generation Cephalosporines Following Ceftriaxone Treatment.
Lead sponsor
Nantes University Hospital
Phase
Not applicable
Overall status
Terminated
Start date
December 19, 2018
Completion date
September 19, 2022
Enrollment
143 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

patients receiving ceftriaxone in hospital emergency unit